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Does the ‘Liverpool Care Pathway’ facilitate
an improvement in quality of care for
dying cancer patients?
C R Mayland*,1, E M I Williams2, J Addington-Hall3, T F Cox4 and J E Ellershaw4
1Marie Curie Palliative Care Institute Liverpool (MCPCIL), University of Liverpool, Liverpool, L3 9TA, UK; 2Department of Public
Health and Policy, University of Liverpool, Liverpool, L69 3BX, UK; 3Faculty of Health Sciences, University of Southampton,
Southampton, SO17 1BJ, UK and 4Cancer Research UK Liverpool Cancer Trials Unit, University of Liverpool, Liverpool, L69 3GL, UK
Background: The Liverpool Care Pathway for the Dying Patient (LCP) aims to transfer hospice principles of care for dying patients
to other health-care sectors. This post-bereavement survey explored the LCP’s effectiveness in improving quality of care for cancer
patients.
Methods: Postal self-completion questionnaires were sent to 778 next-of-kin to consecutive deceased patients who had died
an ‘expected’ cancer death in a hospice and acute tertiary hospital.
Results: Following exclusions (n¼ 53), 255 of the 725 next-of-kin agreed to participate (35.2% response rate). Overall
hospice participants reported the best quality of care, and hospital participants, for whom care was not supported by the LCP,
reported the worst quality of care. Multivariate analysis showed the hospice was an independent predictor for patients
being treated with dignity (OR 8.46) and receiving adequate family support (OR 7.18) (Po0.0001). Care supported by the LCP
and the hospital specialist palliative care team were both associated with good family support, but neither was an independent
predictor.
Conclusions: From the bereaved relatives’ perspective, within the hospital, the LCP is effective in improving specific aspects
of care, such as symptom control for dying patients. Further improvement is required, however, to attain the hospice standard
of care.
Recent end-of-life care policies at both national and international
level have focused on enabling more people to die in their preferred
place of care, which generally is at home (Department of Health,
2008a; Commonwealth of Australia, 2010). Although patients with
terminal cancer can have a more predictable disease trajectory
compared with non-malignant illnesses, difficulties in accurate
prognostication mean a significant proportion of cancer patients
will continue to die in the acute hospital (Dunlop et al, 1989; Auret
et al, 2003). Although a small but steady increase in the proportion
of home deaths (from 18.3 to 20.8%) occurred within the United
Kingdom between 2004 and 2010 (Gomes et al, 2011a), the
majority of patients within many developed countries, including
the United Kingdom, continue to die in hospitals (Costantini et al,
2000; Yang et al, 2006; Gomes and Higginson, 2008b).
Evidence over the last 30 years has demonstrated many
shortcomings in the provision of care for dying cancer patients
within the acute sector (Field, 1989; Mills et al, 1994; Addington-
Hall and O’Callaghan, 2009). Basic principles of palliative care
have not always been practised, often resulting in insufficient
symptom control, poor communication and inadequate psycholo-
gical support for patients and their families (Ellershaw et al,
1997a). One initiative introduced to try to improve care for the
dying was the Liverpool Care Pathway for the Dying Patient (LCP)
(Ellershaw and Wilkinson, 2011b). The LCP is an integrated care
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pathway that aims to transfer the principles of hospice care,
generally regarded as the standard of excellence, into other
settings in a format familiar to the main stream health-care
system. The LCP was recommended in a recent national UK
policy initiative, ‘The Route to Success in end-of-life care in
acute hospitals’, (National End of Life Care Programme, 2010)
specifically linked with the End-of-life Care Strategy (Department
of Health, 2008a), and was also highlighted within the General
Medical Council (GMC) guidance as a document to help facilitate
decision-making and support care for those who are in the last
days of their life (General Medical Council, 2010). Recently,
however, criticism and potential misrepresentation of the LCP has
featured heavily within the UK media.
Previous work demonstrated that UK health-care professionals
perceive the LCP to have a positive impact on patients and families,
and help improve staff confidence levels when caring for dying
patients (Jack et al, 2003). Similar findings were seen in a recent
New Zealand study where the LCP was introduced in two acute
hospital wards; staff perceived that the LCP had a positive benefit
on end-of-life care, assisting with decision-making, communica-
tion and symptom control (Clerk et al, 2012). Results from a pre-
and post-comparison LCP study in the Netherlands have indicated
that from the bereaved relatives’ perspective, symptom control and
some aspects of communication are improved (Veerbeek et al,
2008). Further testing of the LCP’s effectiveness in improving care
and support for dying patients and their families from the user
perspective has not been undertaken within the United Kingdom.
In order to assess the effectiveness of the LCP in transferring
hospice care into the acute sector, the primary aim of this study
was to compare bereaved relatives’ perspectives about the quality of
care in the last days of life for all ‘expected’ cancer deaths in a UK
hospice and acute hospital currently using the LCP. In particular,
two key outcome measures were assessed: whether the patient was
treated with dignity and respect, and whether the family was
adequately supported.
MATERIALS AND METHODS
A post-bereavement survey was conducted with next-of-kin to
cancer patients who had died within the chosen hospice or acute
tertiary hospital in Liverpool. All consecutive patients who had
died within a 21-month period (during 2005 or 2006) were
included according to the following eligibility criteria:
(i) over 18 years of age;
(ii) had an ‘expected death’ defined as either having their care
supported by the LCP (version 11) or had a ‘Not for
resuscitation’ decision documented, and the cause of death on
the death certificate was not sudden in nature.
Database records of all the deaths and patients’ next-of-kin were
cross-referenced against the LCP database, the Patient Adminis-
tration database (within the hospice) and a Bereavement database
(within the hospital); the latter records whether or not the patient’s
care was supported by the LCP and the resuscitation decision made
by the patients’ responsible medical team. Manual checking of
hospice case records and hospital bereavement records (stating
cause of death on the death certificates) was undertaken to exclude
sudden or unexpected deaths (Supplementary Figure 1) by the
primary researcher (CM), and any uncertainties were discussed
with a second researcher (JE).
Sample size was calculated using a previous post-bereavement
study with ‘Views Of Informal Carers – Evaluation of Services’
(VOICES) questionnaire, which showed that 97% bereaved
relatives perceived that their family member was treated with
dignity ‘always’ or ‘most of the time’ in the hospice, compared with
70% for those in the hospital (Addington-Hall and O’Callaghan,
2009). We hypothesised that 95% of relatives would perceive that
patients were treated with dignity in the hospice and 80% in the
hospital. Using 5% significance level and 90% power, a sample size
of B100 relatives was needed from each setting (hospice and
hospital). By estimating a response rate of 40%, the total sample
size required was at least 500 participants.
An information pack including the questionnaire, ‘Evaluating
Care and Health Outcomes – for the Dying’ (ECHO-D) was sent
out to 778 next-of-kins during 2006, at least 3 months following
the bereavement. ECHO-D consists of 91 items, was developed
from the goals of the LCP document, the existing post-bereave-
ment surveys (including VOICES) and aspects of a ‘good death’
determined from the literature, and has been shown to be valid and
reliable (Mayland, 2010; Mayland et al, 2012b). Reminder letters
were sent out 4 weeks after the first mailing to non-respondents.
Ethical approval was obtained from Liverpool (Adult) Ethics
Committee (05/Q1505/126).
Data were analysed using SPSS version 16 and Statistical
Analysis System (SAS) version 9.2 (University of Liverpool,
Liverpool, UK). Comparisons of demographic data used w2 tests,
independent sample t-testing and Mann–Whitney U-testing.
Comparisons between questionnaire responses used the Pearson’s
w
2 statistic with 95% confidence intervals. For questions with ordinal
response options, the Cochran–Mantel–Haenszel test was conducted
using standardized mid-rank scores. Forced entry logistic regression
was conducted to determine whether any demographic differences
independently predicted responses to two key outcome measures:
whether the patient was treated with dignity and respect, and
whether the family was adequately supported.
RESULTS
Of the 778 eligible to participate patients, 52 were excluded (next-
of-kin had either died (n¼ 3) or moved house (n¼ 49) with no
forwarding contact details). This left 726 potential participants, of
whom 255 agreed to participate (35.1% response rate). Response
rate was higher for the hospice next-of-kin compared with the
hospital group (40.5% (109 of 269) vs 31.9% (146 of 457) w2 5.46,
P¼ 0.02). An additional 141 (18.1%) returned their response
forms, but declined participation, citing ‘emotional distress’ as the
most common reason. Non-participants had a higher proportion
of ‘other (for example, unknown primary)’ as the patient’s primary
site of cancer compared with participants (n¼ 128 (27.2%) vs
n¼ 42 (16.5%), w2 10.57, Po0.001) (Supplementary Table 6). All
patients who died an ‘expected death’ in the hospice were cared for
by the LCP, with the others (n¼ 73) having a more acute decline
due to complications from their illness or being unable to retrieve
case notes to clarify details. Within the hospital, for those who
completed the ECHO-D questionnaire, 78 (53.4%) deceased patients
had their care supported by the LCP (‘Hospital with LCP’ group)
and 68 (46.6%) did not (‘Hospital without LCP’ group).
For participants, demographic details of deceased patients and
their next-of-kin were compared (Table 1 and Supplementary
Table 7). Deceased hospice patients, compared with hospital
patients, were younger (68.5 vs 72.3 years, P¼ 0.02), more likely to
be female (57.8% vs 45.9%, P¼ 0.05) and more likely to have breast
cancer (12.8% vs 3.4%, P¼ 0.005). Deceased ‘Hospital with LCP’
patients, compared with deceased ‘Hospital without LCP’ patients
(Table 1), were older (74.6 vs 69.6 years, P¼ 0.02) and more likely
to have had hospital specialist palliative care team (HSPCT)
involvement (44.9% vs 28.4%, P¼ 0.04). The median time since
bereavement was significantly shorter for the ‘Hospital with LCP’
participants (276.0 days) compared with ‘Hospital without LCP’
participants (415.5 days) (U 1628.5, Po0.0001).
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Symptom control. With the exception of retained respiratory
tract secretions, the ‘Hospital without LCP’ participants reported
the highest symptom burden for their next-of-kin (Table 2).
Hospice participants were most likely to be satisfied and the
‘Hospital without LCP’ participants least likely to be satisfied with
the level of symptom control (Table 2). The level of satisfaction for
‘Hospital with LCP’ participants’ was between these two levels. For
example, seventy-eight (72.2%) hospice participants responded
that doctors and nurses had done enough to relieve the pain ‘all of
the time’ compared with 46 (59.0%) ‘Hospital with LCP’
participants and 23 (33.8%) ‘Hospital without LCP’ participants
(Po0.0001). Similar differences were seen for the control of
restlessness and breathlessness.
Communication. Responses indicated that more open discussion
about the provision and withdrawal of fluids in both health-care
settings was needed, but especially in the acute hospital (Hospice
n¼ 20, 18.3%, ‘Hospital with LCP’ n¼ 33, 42.3%, ‘Hospital
without LCP’ n¼ 33, 48.5%, p¼ 0.003) (Table 3). Discussions
informing participants that their family member was likely to die
occurred on a similar frequency in both health-care settings
(Hospice n¼ 83, 76.9%, ‘Hospital with LCP’ n¼ 61, 78.2%,
‘Hospital without LCP’ n¼ 46, 67.6%; P¼NS) and generally were
of good quality. More hospice participants (n¼ 44, 40.4%)
reported conversations with health-care professionals about what
to expect when their loved one died compared with the ‘Hospital
with LCP’ (n¼ 22, 28.8%) and ‘Hospital without LCP’ (n¼ 11,
16.2%) participants (P¼ 0.002).
Key outcomes – dignity and respect, and family support.
Univariate analysis showed that the only variable associated with
patients ‘always’ being treated with dignity and respect was when
they received hospice care (OR 8.46, Po0.0001) (Table 4).
Similarly, participants perceived that they were adequately
supported when care was provided by the hospice (OR 7.18,
Po0.0001) (Table 5). Participants within the hospital perceived
that they were adequately supported when care was supported by
the LCP (P¼ 0.04) and when the HSPCT were involved (P¼ 0.04),
although multivariate analysis showed that neither was an
independent predictor (LCP P¼ 0.08; HSPCT P¼ 0.09)
(Supplementary Table 8).
DISCUSSION
To our knowledge, this is the first post-bereavement study within
the United Kingdom that explores the impact of the LCP on the
quality of care for dying cancer patients from the user’s
perspective. Overall, hospice participants reported the highest
quality of care for dying patients and their families, and the
‘Hospital without LCP’ participants reported the lowest quality of
care. The quality of care reported by the ‘Hospital with LCP’
participants was reported as being in between these two levels. The
overall aim and philosophy of the LCP is to transfer the principles
and ‘best practice’ of hospice care into the acute hospital setting.
This study demonstrates that for some aspects of care, such as
symptom control, this cultural shift appears to be occurring,
Table 1. Comparison of demographic details for deceased patients and their next-of-kin for the different participant groupsa
Hospice
(n¼109)
All hospital
(n¼146)
P-value
Hospitalþ LCP
(n¼78)b
Hospital LCP
(n¼68)
P-value
Deceased patient
Mean±s.d. or number (%)
or median (IQR)
Mean±s.d. or number (%)
or median (IQR)
Age (years) 68.5±12.9 72.3±12.5 0.02 74.6±10.9 69.6±13.7 0.02
Number of females 63 (57.8) 67 (45.9) 0.05 38 (48.7) 30 (44.1) NS
Median length of final admission
(days)
15 (6.5–28.0) 11.5 (4.75–25.0) NS 12.0 (5.75–23.0) 10.0 (4.0–27.0) NS
Primary site of cancer
Lung 32 (29.4) 29 (19.9) NS 17 (21.8) 12 (17.6) NS
Colorectal 12 (11.0) 14 (9.6) NS 8 (10.2) 6 (8.8) NS
Oesophagus 10 (9.2) 6 (4.1) NS 5 (6.4) 1 (1.5) NS
Stomach 6 (5.5) 7 (4.8) NS 3 (3.8) 4 (5.9) NS
Pancreas 5 (4.6) 19 (13.0) 0.02 11 (14.1) 8 (11.8) NS
Bladder 3 (2.8) 8 (5.5) NS 5 (6.4) 3 (4.4) NS
Non-Hodgkin’s lymphoma 0 (0.0) 5 (3.4) 0.06 3 (3.8) 2 (2.9) NS
Leukaemia 0 (0.0) 13 (8.9) 0.001 4 (5.1) 9 (13.2) NS
Prostate 5 (4.6) 11 (7.5) NS 6 (7.7) 5 (7.4) NS
Breast 14 (12.8) 5 (3.4) 0.005 1 (1.3) 4 (5.9) NS
Ovary 5 (4.6) 3 (2.1) NS 3 (3.8) 0 (0.0) NS
Other 17 (15.6) 25 (17.1) NS 12 (15.4) 14 (20.6) NS
HSPCTc involvement NA NA NA 35 (44.9) 19 (28.4) 0.04
Next-of-kin (participant)
Number of female participants 70 (64.2) 93 (63.7) NS 46 (59.0) 43 (63.2) NS
Median time since bereavement
(days)
341 (221–486) 324.5 (194–497) NS 276.0 (167–446.8) 415.5 (266–541.8) o0.0001
a
Comparisons between groups were made using the independent sample t-testing for continuous parametric data, Pearson’s w2 statistic for categorical data (Fisher’s exact test if expected
frequencies were less than five), and Mann–Whitney U for continuous non-parametric data.
b
‘Hospitalþ LCP’¼patient’s care was supported by the LCP before death; ‘hospital LCP’¼patient’s care was not supported by the LCP before death.
c
HSPCT¼ hospital specialist palliative care team; NS¼nonsignificant (P40.05). Bold values indicate the statistically significant results.
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whereas for others, including aspects of communication, more is
required to be done to try to attain the hospice standard of care.
The main limitation of the study is the response rate of 35.1%,
which is comparatively low and lower than the 40% response rate
we had estimated. This can lead to the introduction of non-
response bias and limit the generalisability of the findings to the
whole population. Post-bereavement research studies represent a
difficult and sensitive area of work, and this is likely to be the
main and most important reason for the low response rate. There
was almost a 10% difference in the response rate between the two
health-care settings, with a greater response from hospice
participants. This may be related to the differing settings for the
two institutions, that is, urban area for acute hospital and more
affluent ‘conservation’ area for the hospice; a higher degree of
altruism towards the hospice (which is a recognised charity); or
that those who had a more positive experience were more
motivated to provide feedback about the care. Our response rate
is comparable with two other recent UK studies using post-
bereavement questionnaires (NHS Lothian, 2007; Young et al,
2008). The response rate, however, is lower than the recent UK
National VOICES Bereavement Survey (response rate of 45.7%)
(Department of Health, 2012b), although this survey had three
Table 2. Symptom control: comparison of bereaved relatives’ views in the hospice as opposed to the hospitala
Hospice (1),
(n¼109)
Hospitalþ LCP (2),
(n¼78)
Hospital LCP (3),
(n¼68)
n % 95% CI n % 95% CI n % 95% CI P-valueb
In your opinion, during the last 2 days, did she/he appear to be in pain? (missing n¼2, 0.8%)
Yes, all of the time 9 8.3 4.2–14.5 6 7.7 3.3–15.2 10 14.7 7.8–24.5 NS
Yes, some of the time 44 40.4 31.5–49.7 41 52.6 41.6–63.4 26 38.2 27.4–50.1
No, she/he did not appear to be in pain 54 49.5 40.3–58.8 31 39.7 29.4–50.8 32 41.7 35.5–58.8
In your view, did the doctors and nurses do enough to help relieve the pain? (missing n¼5, 2.0%)
Yes, all of the time 78 72.2 62.6–79.4* 46 59.0 47.9–69.4** 23 33.8 23.4–45.6 o0.0001
Yes, some of the time 8 7.4 3.5–13.4* 13 16.7 9.7–26.1 18 26.5 17.1–37.8
No, not at all 0 0.0 0.0–2.3* 3 3.8 1.1–9.9 7 10.3 4.7–19.2
Not applicable, she/he was not in pain 21 19.4 12.7–27.4 14 17.9 10.7–27.6 19 27.9 18.4–39.4
In your opinion, during the last 2 days, did she/he appear restless? (missing n¼5, 2.0%)
Yes, all of the time 8 7.3 3.5–13.4* 7 9.0 4.1–16.8 17 25.0 15.9–36.2 o0.0001
Yes, some of the time 52 47.7 38.5–57.0 35 44.9 34.2–55.9 38 55.9 44.0–67.2
No, she/he did not appear to be restless 46 42.2 33.2–51.6* 35 44.9 34.2–55.9** 12 17.6 10.0–28.0
In your view, should more have been done by the doctors and nurses to help relieve his/her restlessness? (missing n¼14, 5.5%)
Yes 11 10.2 5.5–16.8* 15 19.5 11.7–29.0 27 39.7 28.7–51.6 o0.0001
No 50 46.3 36.7–55.2 30 39.0 28.2–49.5 26 38.2 27.4–50.1
Not applicable, she/he was not restless 42 38.9 29.8–47.9 29 37.7 27.1–48.2** 11 16.2 8.9–26.3
In your opinion, during the last 2 days, did she/he appear to have a ‘noisy rattle’ to his/her breathing? (missing n¼10, 3.9%)
Yes, all of the time 22 20.2 13.5–28.4* 10 12.8 6.8–21.6 2 2.9 0.6–9.1 NS
Yes, some of the time 41 37.6 28.9–46.9 30 38.5 28.2–49.5 33 48.5 36.9–60.3
No, she/he did not appear to have a ‘noisy rattle’ to the breathing 43 39.4 30.7–48.8 35 44.8 34.2–55.9 29 42.6 31.4–54.5
Should more have been done to relieve the ‘noisy rattle’? (missing n¼27, 10.6%)
Yes 18 16.5 10.5–24.3 12 15.4 8.7–24.6 11 16.2 8.9–26.3 NS
No 42 38.5 29.8–47.9 23 29.5 20.3–40.1 19 27.9 18.4–39.4
Not applicable, there was no ‘noisy rattle’ to his/her breathing 39 35.8 27.3–45.1 35 44.9 34.2–55.9 29 42.6 31.4–54.5
In your opinion, during the last 2 days, did she/he appear breathlessness? (missing n¼8, 3.1%)
Yes, all of the time 16 14.7 9.0–22.2 11 14.1 7.7–23.1 21 30.9 20.9–42.5 0.0006
Yes, some of the time 35 32.1 23.9–41.3 24 30.8 21.4–41.6 28 41.2 30.1–53.0
No, she/he did not appear breathless 54 49.5 40.3–58.8* 40 51.3 40.3–62.2** 18 26.5 17.1–37.8
In your view, should more have been done to help relieve the breathlessness? (missing n¼27, 10.6%)
Yes 6 5.6 2.3–11.0* 11 14.1 7.7–23.1 16 23.5 14.7–34.6 o0.0001
No 35 32.4 23.9–41.3 20 25.6 17.0–36.1 28 41.2 30.1–53.0
Not applicable, she/he was not breathless 55 50.9 41.2–59.7 40 51.3 40.3–62.2** 17 25.0 15.9–36.2
Abbreviations: CI¼ confidence interval; LCP¼ Liverpool Care Pathway for the Dying Patient.
a
Confidence intervals with * indicate significant differences between columns 1 and 3; confidence intervals with ** indicate significant differences between columns 2 and 3; percentages do not
always add up to 100% due to missing responses (total number of missing responses stated within table).
b
Comparisons between groups were conducted using w2 testing and additional testing using the Cochran–Mantel–Haenszel test if question had ordinal response options. Bold values indicate
the statistically significant results.
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mail-outs, a practice which was not permitted by our ethical
committee. Overall, our participants were similar to our non-
participant group, with the exception that non-participants were
more likely to have ‘other (for example, unknown primary)’ as
their primary site of cancer. We do not have, however, information
on other demographic factors known to influence response rates,
therefore, caution is needed about the generalisability of our
results. The second limitation of this study is the difficulty in
clarifying the sole extent to which the LCP influenced perceptions
and the role of other factors, such as communication skills teaching
and the HSPCT. In part, this relates to only have single study sites
for the hospice and hospital, and potentially to our sample size.
As most of our analysis compares three groups, our study may
have been underpowered (ideally we should have obtained 100
Table 3. Communication with the health-care team (HCT) and overall impressions: comparison of bereaved relatives’ views in the hospice as opposed to
the hospitala
Hospice (1), (n¼109) Hospitalþ LCP (2), (n¼78) Hospital LCP (3), (n¼68)
n % 95% CI n % 95% CI n % 95% CI P-valueb
Did any of the doctors or nurses discuss with you the appropriateness of giving fluids through a ‘drip’ in the last 2 days of life?
(missing n¼13, 5.1%)
Yes 29 26.6 19.0–35.4 22 29.3 19.1–38.9 16 25.0 14.7–34.6 NS
No 66 60.6 51.2–69.4 47 62.7 49.2–70.6 46 71.9 56.0–77.9
Do not know 8 7.3 3.5–13.4 6 8.0 3.3–15.2 2 3.1 0.6–9.1
If no: would these types of discussion have been helpful? (missing n¼19, 7.5%)
Yes 20 18.3 12.0–26.4*,w 33 42.3 31.8–53.4 33 48.5 36.9–60.3 0.003
No 35 32.1 23.9–41.3* 11 14.1 7.7–23.1 8 11.8 5.7–21.0
Before she/he died, were you told she/he was likely to die? (missing n¼11, 4.3%)
Yes 83 76.1 67.5–83.4 61 78.2 68.1–86.2 46 67.6 56.0–77.9 NS
No 20 18.5 12.0–26.4 13 16.7 9.7–26.1 21 30.9 20.9–42.5
Was it the first time you were aware she/he was dying? (NA response n¼43, 19.9%; missing n¼18, 7.1%)
Yes 10 12.2 6.4–20.3w,* 26 42.6 30.8–55.1 17 37.0 24.1–51.4 0.004
No 66 80.5 69.9–87.1w,* 33 54.1 41.7–66.2 25 54.3 40.1–68.1
Do not know 2 2.4 0.5–7.5 0 0.0 0.0–4.0 2 2.4 0.9–13.2
Did you have enough privacy when you were told? (NA response n¼46, 18.0%; missing n¼16, 6.3%)
Yes 74 89.2 81.2–94.5 49 80.3 69.1–88.8 37 80.4 67.3–89.9 NS
No 3 3.6 1.0–9.3 8 13.1 6.4–23.2 7 15.2 7.1–27.6
Do not know 2 2.4 0.5–7.5 2 3.3 0.7–10.1 0 0.0 0.0–5.3
Were you told in a sensitive manner? (NA response n¼46, 18.0%; missing n¼23, 9.0%)
Yes 75 90.4 82.6–95.3 53 86.9 76.8–93.6 40 86.9 75.1–94.4 NS
No 0 0.0 0.0–3.0 4 6.6 2.3–14.8 3 6.5 1.9–16.4
Did a member of the HCT talk to you about what would happen at the time of his/her death? (missing n¼10)
Yes 44 40.4 *31.5–49.7 22 28.8 19.1–38.9 11 16.2 8.9–26.3 0.002
No 61 56.0 *46.6–65.0 52 66.7 55.8–76.4 55 80.9 70.4–88.8
If no: would this type of discussion have been useful? (NA response n¼69, 3.9%; missing n¼21, 8.2%)
Yes 26 23.9 *16.6–32.5 25 32.1 22.5–42.9** 42 61.8 49.9–72.6
No 28 25.7 18.2–34.5 24 30.8 21.4–41.6 10 14.7 7.8–24.5 0.001
How much of the time was she/he treated with dignity and respect by the HCT? (missing n¼2, 0.8%)
Always 97 89.0 82.1–93.8w,* 45 57.7 46.6–68.2 29 42.6 31.4–54.4 o0.0001
Most of the time 11 10.1 5.5–16.8w,* 24 30.8 21.4–41.6 24 35.3 27.7–47.1
Some of the time/never 0 0.0 0.0–2.3w,* 8 10.3 5.0–18.4 13 19.1 11.2–29.6
Do not know 0 0.0 0.0–2.3 1 1.3 0.1–5.8 1 1.5 0.2–6.7
Overall, in your opinion, were you adequately supported by the HCT? (missing n¼20, 7.8%)
Yes 95 88.0 79.9–92.4w,* 52 67.5 55.8–76.4 35 52.2 39.7–63.1 o0.0001
No 7 6.5 2.9–12.2w,* 19 24.7 15.9–34.7 27 40.3 28.7–51.5
Abbreviations: CI¼ confidence interval; LCP¼ Liverpool Care Pathway for the Dying Patient.
a
Confidence intervals with w indicate significant differences between columns 1 and 2; confidence intervals with * indicate significant differences between columns 1 and 3; confidence intervals
with ** indicate significant differences between columns 2 and 3; percentages do not always add up to 100% due to missing responses (total number of missing responses stated within table).
b
Comparisons between groups were conducted using w2 testing and additional testing using the Cochran–Mantel–Haenszel test if question had ordinal response options. Bold values indicate
the statistically significant results.
BRITISH JOURNAL OF CANCER Liverpool Care Pathway and cancer patients
1946 www.bjcancer.com |DOI:10.1038/bjc.2013.203
participants for each group). The ‘Hospital with LCP’ participants
more frequently had involvement from the HSPCT, which is likely
to have had a positive impact on the perceptions of care. A
previous systematic review assessing the effect of specialist
palliative care teams (both hospital and community) showed
benefit in terms of satisfaction with care and symptom control
(Hearn and Higginson, 1998). Additionally, a further review
specifically of hospital teams showed small positive benefits,
although limitations in the study design affected assessment
(Higginson et al, 2002). The HSPCT within our study hospital
was established in 1994, limiting the potential time-lag benefit, but
clarifying the extent of the involvement of the HSPCT on both
hospital groups, would be useful. Our choice of study groups would
also influence this and may have introduced selection bias. Ideally,
we would have liked to also have had a ‘Hospice without LCP’
group and be certain that the ‘Hospital without LCP’ group was a
representative group, that is, that the death was expected and care
could have, and potentially should have, been supported by the
LCP. The third limitation relates to the fact that the bereaved
relatives’ views cannot be assumed to be the same as that of the
deceased patient. Post-bereavement studies, however, have certain
advantages: they can reflect care for all those who have died rather
than just those who are well enough to participate; and they
provide additional information about the participants’ own
experience, as well as provide ‘proxy’ information about patient
care (Fowler et al, 1999).
One of the strengths of this study is the specific detail obtained,
thus providing a comprehensive picture about care for the dying
cancer patients and identifying the areas that require improvement.
Although aspects of communication were of a similar quality in
both health-care settings, there was still unmet need for
information about the provision and withdrawal of fluids and
what to expect when someone dies, with the greatest degree of
unmet need seen for the ‘Hospital without LCP’ participants.
Adequate control of distressing symptoms in the last days of life is
a key component of good care. Hospice and ‘Hospital with LCP’
participants reported very similar symptom prevalence and with
the exception of retained respiratory tract secretions, reported a
lower symptom burden compared with the ‘Hospital without LCP’
participants. These findings may be related to a genuine difference
in symptom prevalence, with patients from the ‘Hospital without
LCP’ group having more complex symptoms. Alternatively, this
could indicate that the LCP is encouraging a more intensive and
pro-active approach to symptom control, which would be in
keeping with the findings from a Scottish study undertaken in eight
care homes using the LCP (Hockley et al, 2005), and a North
American study that used the ‘Palliative Care for Advanced
Disease’ integrated pathway in the last days of life (Bookbinder
et al, 2005). A further consideration is the influence of the shorter
time since bereavement for the ‘Hospital with LCP’ participants.
This was mainly related to difficulties retrieving accurate next-of-
kin details for the ‘Hospital without LCP’ group (more likely to be
missing or incomplete), which required retrieval of the medical
case notes. Perceptions about quality of care over time can change,
with pain and depression tending to be reported as less frequent
and severe as time passes (McPherson and Addington-Hall, 2004).
Table 4. Univariate analysis of demographic details predicting likelihood
of participants perceiving that patients were treated with dignity and
respect all of the time
Independent item Exp (B) (95% CI)a P-value
Place of care
Hospital Ref. cat.
Hospice 8.46 (4.19–17.10) o0.0001
Patient age 0.99 (0.98–1.02) 0.84
Patient gender 0.83 (0.49–1.41) 0.50
Patient diagnosis
Others Ref. cat. 0.17
Lung 0.85 (0.38–1.88) 0.69
Prostate 0.75 (0.23–2.38) 0.62
Colorectal 3.43 (0.91–13.0) 0.07
Oesophagus 6.71 (0.82–54.99) 0.08
Stomach 0.63 (0.17–2.26) 0.47
Bladder 0.67 (0.17–2.69) 0.57
Pancreas 0.38 (0.14–1.01) 0.06
Leukaemia 0.54 (0.14–2.00) 0.36
NHL 0.67 (0.10–4.39) 0.68
Breast 1.34 (0.36–4.77) 0.65
Ovary 0.60 (0.12–2.96) 0.53
Care supported by LCP
Hospital without LCP Ref. cat.
Hospital with LCP 1.80 (0.92–3.49) 0.09
Patient age 1.01 (0.98–1.04) 0.51
Median time since bereavement 1.00 (0.99–1.00) 0.61
HSPCT involvement 0.96 (0.49–1.87) 0.89
Abbreviations: CI¼ confidence interval; HSPCT¼ hospital specialist palliative care team;
LCP¼ Liverpool Care Pathway for the Dying Patient.
a
Exp (B) or exponential of the beta represents the odds ratio of the association between the
dependant variable (whether participant was adequately supported by the health-care
team) and the independent variables (patient demographic details). Bold values indicate the
statistically significant results.
Table 5. Univariate analysis of demographic details predicting likelihood
of participants perceiving themselves to be adequately supported by
health-care team
Independent item Exp (B) (95% CI)a P-value
Place of care
Hospital Ref. cat.
Hospice 7.18 (3.08–16.73) o0.0001
Patient age 0.99 (0.96–1.01) 0.31
Patient gender 0.97 (0.53–1.80) 0.93
Patient diagnosis
Others Ref. cat. 0.84
Lung 0.99 (0.39–2.50) 0.98
Prostate 0.71 (0.19–2.69) 0.62
Colorectal 1.57 (0.45–5.45) 0.48
Oesophagus 1.57 (0.31–8.08) 0.59
Stomach 2.57 (0.30–22.37) 0.39
Bladder 1.14 (0.21–6.11) 0.88
Pancreas 0.46 (0.16–1.38) 0.17
Leukaemia 0.67 (0.15–2.98) 0.60
NHL 0.43 (0.06–2.87) 0.38
Breast 1.24 (0.30–5.07) 0.77
Ovary 1.71 (0.19–15.66) 0.63
Care supported by LCP
Hospital without LCP Ref. cat.
Hospital with LCP 2.11 (1.02–4.37) 0.04
Patient age 1.0 (0.97–1.03) 0.99
Median time since bereavement 1.0 (0.99–1.00) 0.53
HSPCT involvement 2.21 (1.02–4.76) 0.04
Abbreviations: CI¼ confidence interval; HSPCT¼ hospital specialist palliative care team;
LCP¼ Liverpool Care Pathway for the Dying Patient.
a
Exp (B) or exponential of the beta represents the odds ratio of the association between the
dependant variable (whether participant was adequately supported by the health-care
team) and the independent variables (patient demographic details). Bold values indicate the
statistically significant results.
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If this principle was applied to our study, it would suggest an
underestimation of the symptom severity within the ‘Hospital
without LCP’ group, and that the differences may have been
actually greater than our reported findings.
Further clarification about the role of other external influencing
factors is merited by assessing quality of care for the dying in the
institutions that use an integrated care pathway with comparable
ones, which do not. Since this study has been conducted, version
12 of the LCP has been launched (Ellershaw and Wilkinson,
2011b), with more detailed documentation about the decisions
relating to clinically assisted hydration and nutrition. Further
evaluation of the impact of these changes is required, ideally by
using a before- and after-study approach. Additionally, in order to
clarify whether it is simply the bereaved relatives’ perceptions that
are altered or whether there is a significant change in clinical
practice when the LCP is used to support care, an observational
study would be beneficial. Although our results suggest that there
has been some improvement in care for dying cancer patients
within the hospital when the LCP is used, further progress is
needed to be able to deliver care, which is more comparable with
the hospice standard. Ongoing review and updating of the LCP as
well as educational initiatives focusing on pertinent end-of-life
discussions would be practical ways to facilitate this, and to
hopefully further improve the experience of the dying patients and
their families in the hospital sector.
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